SCHEMBL3795296

SCHEMBL3795296

NC(=O)C1c2ccccc2-c2c(-c3ccc(F)nc3)cccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.38
DHODH Q02127 1/20 0.38
CYP2A6 P11509 2/20 0.37
CYP2B6 P20813 2/20 0.37
CYP2E1 P05181 1/20 0.37
CHEK2 O96017 2/20 0.36
SCN9A Q15858 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
FEN1 P39748 3/20 0.34
ALOX5AP P20292 2/20 0.34
LMNA P02545 1/20 0.34
EDNRB P24530 2/20 0.33
EDNRA P25101 2/20 0.33
MAP4K4 O95819 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
JAK1 P23458 2/20 0.33
JAK3 P52333 2/20 0.33
JAK2 O60674 1/20 0.33
TYK2 P29597 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3795301 0.81 CYP2A6 (0.38) DHODHCYP2A6CYP2B6CYP2E1SCN9A
SCHEMBL3798573 0.80 PDK2 (0.41) ATMFEN1ALOX5APLMNAKCNH2
SCHEMBL3800951 0.79 MAP4K4 (0.44) CYP2A6MAP4K4
SCHEMBL27776603 0.77 CYP2A6 (0.38) DHODHCYP2A6CYP2B6CYP2E1SCN9A
SCHEMBL3800136 0.76 CNR2 (0.55) JAK1ALDH1A1
SCHEMBL3795696 0.75 CDK8 (0.53) CHEK2FEN1ALOX5APMAP4K4JAK2
SCHEMBL3791962 0.73 HSP90AA1 (0.42) ATMLMNAJAK3JAK2ALDH1A1
SCHEMBL3797695 0.71 CSNK1A1 (0.58) ATMALDH1A1
SCHEMBL4077067 0.71 CSNK1A1 (0.58) ATMALDH1A1
SCHEMBL3143561 0.71 ATM (0.61) ATMLMNAEDNRBEDNRAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130503-A1 NEW FLUORENE DERIVATIVES, COMPOSITIONS CONTAINING THE SAME AND USE THEREOF AS INHIBITORS OF THE PROTEIN CHAPERONE HSP 90 SANOFI-AVENTIS (FR) 2010-05-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130503-A1 NEW FLUORENE DERIVATIVES, COMPOSITIONS CONTAINING THE SAME AND USE THEREOF AS INHIBITORS OF THE PROTEIN CHAPERONE HSP 90 HSP90AB2P, HSPA2, HSP90AB1 ATM 3750/4885DHODH 2907/4885CYP2A6 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.